"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened..: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".
the publication�s purpose is to be a "force for good and a platform for much needed change and to generate critical debate"..
may 16, 2018.
.